Phase II trial of temozolomide and irinotecan as second-line treatment for advanced non-small cell lung cancer

Nicholas W. Choong, Ann M. Mauer, Philip C. Hoffman, Charles M. Rudin, Jerome D. Winegarden, J. Lee Villano, Mark Kozloff, James L. Wade, David F. Sciortino, Livia Szeto, Everett E. Vokes*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of temozolomide and irinotecan as second-line treatment for advanced non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences